26.88000 EUR
1.355
5.31%
Last update Dec 12, 8:11 AM CET
Main market
Day range
26.88000
26.88000
Previous close
25.52500
Open
26.88000
Access this stock data via API
Subscribe
TG Therapeutics, Inc.
26.88
1.36
5.31%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 280.2M 233.7M 2.8M 6.7M
Cost of revenue 32.8M 14.1M 265K 790K
Gross profit 247.5M 219.5M 2.5M 5.9M
Operating expense
Research & development 80.3M 76.2M 125.4M 222.6M
Selling general and admin 131.4M 122.7M 70.0M 128.1M
Other operating expenses
Operating income 35.7M 20.6M -192.8M -344.8M
Non operating interest income
Income
Expense 20.5M 12.6M 10.2M 5.6M
Other income expense 6.6M 5.0M 4.7M 2.3M
Pretax income 21.8M 13.1M -198.3M -348.1M
Tax provision 1.9M 390K 0 0
Net income 19.9M 12.7M -198.3M -348.1M
Basic EPS 0.2 0.1 -1.5 -2.6
Diluted EPS 0.2 0.1 -1.5 -2.6
Basic average shares 123.8M 148.9M 140.9M 137.6M
Diluted average shares 123.8M 148.9M 140.9M 137.6M
EBITDA 42.5M 26.1M -187.6M -342.0M
Net income from continuing op. 19.9M 12.7M -198.3M -348.1M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 8 hours 42 minutes

11:17
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).